Skip to main content
TipRanks
Go Ultimate75% OFF

Ocumension Therapeutics (1477) Financial Statements

2 Followers

Ocumension Therapeutics Financial Overview

Ocumension Therapeutics's market cap is currently ¥3.85B. The company's EPS TTM is ¥-0.15; its P/E ratio is -26.15; Ocumension Therapeutics is estimated to report earnings on March 19, 2027, and the estimated EPS forecast is ¥0.05. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 804.35M¥ 417.31M¥ 246.37M¥ 158.96M¥ 56.15M
Gross Profit¥ 360.92M¥ 225.06M¥ 144.37M¥ 102.92M¥ 36.94M
Operating Income¥ -160.20M¥ -306.43M¥ -402.15M¥ -455.86M¥ -385.20M
EBITDA¥ -16.47M¥ -176.48M¥ -320.62M¥ -359.98M¥ -245.53M
Net Income¥ -158.82M¥ -268.27M¥ -379.79M¥ -402.64M¥ -259.99M
Balance Sheet
Cash & Short-Term Investments¥ 402.63M¥ 769.21M¥ 1.05B¥ 1.29B¥ 1.77B
Total Assets¥ 4.09B¥ 3.97B¥ 3.27B¥ 3.04B¥ 3.33B
Total Debt¥ 187.62M¥ 25.78M¥ 137.98M¥ 29.58M¥ 11.21M
Net Debt¥ -215.02M¥ -703.42M¥ -704.86M¥ -1.14B¥ -1.11B
Total Liabilities¥ 410.38M¥ 200.19M¥ 351.03M¥ 295.04M¥ 222.88M
Stockholders' Equity¥ 3.68B¥ 3.77B¥ 2.92B¥ 2.75B¥ 3.11B
Cash Flow
Free Cash Flow¥ -358.65M¥ -408.97M¥ -539.79M¥ -510.66M¥ -861.66M
Operating Cash Flow¥ -105.29M¥ -178.83M¥ -177.93M¥ -200.66M¥ -196.85M
Investing Cash Flow¥ -361.46M¥ 275.91M¥ -259.78M¥ 229.15M¥ -1.35B
Financing Cash Flow¥ 118.04M¥ -213.79M¥ 108.66M¥ -9.22M¥ 668.85M

Currency in CNY

Ocumension Therapeutics Earnings and Revenue History

-3B-1.5B01.5B-750000 %-500000 %-250000 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Ocumension Therapeutics Liabilities to Assets

01.5B3B4.5B0 %400 %800 %1200 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Ocumension Therapeutics Cash Flow

-1.5B-1B-500M0500M1B1.5B2B20182019202020212022202320242025OperatingInvestingFinancing

Ocumension Therapeutics Forecast EPS vs Actual EPS

-0.4-0.3-0.2-0.100.1Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss